# Intensity Therapeutics, Inc.: Form 8-K, filed Jul 17, 2024

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: 8-K
- Filed: 2024-07-17
- Accepted by EDGAR: Jul 17, 2024, 16:01 ET
- Period: 2024-07-17
- Accession: 0001567264-24-000035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/intensity-20240717.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/intensity-20240717.htm

Filed Jul 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001567264-24-000035. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.
